The HDL Handbook: Biological Functions and Clinical Implications, Third Edition, brings laboratory research in HDL from bench to bedside in a reference format for both researchers and clinicians studying cholesterol, lipids, epidemiology, biochemistry, molecular medicine, and pathophysiology of cardiovascular diseases. Information presented is valuable for the development of clinical trials with the aim of improvement of HDL-C levels and the prevention of cardiovascular events. Highlights of this new edition include the science underpinning HDL metabolism including information on HDL-C metabolism, gene expression, gene-bioactive compounds interaction, and post-translational modifications of gene expression of apo-lipoproteins.
Rezensionen / Stimmen
"This book accomplishes its goal of bringing laboratory research from the bench to the bedside in a format that can be used by researchers and clinicians alike who are studying HDL cholesterol."--Doody's
Auflage
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science Publishing Co Inc
Zielgruppe
Für Beruf und Forschung
Researchers and clinicians studying cholesterol, lipids, epidemiology, biochemistry, molecular medicine, and pathophysiology of cardiovascular diseases
Maße
Höhe: 229 mm
Breite: 152 mm
Gewicht
ISBN-13
978-0-12-812513-7 (9780128125137)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Dr. Komoda is a visiting professor at Toho University School of Medicine in Japan. He has extensive expertise with research in alkaline phosphatase, amylase, and oxidized HDL. He co-operated the intestinal alkaline phosphatase at Washington University School of Medicine in St. Louis, Missouri. He is the recipient of the Kodama Memorial Award from Japanese Society of Electrophoresis.
Herausgeber*in
Visiting Professor, Toho University School of Medicine, Japan
1. Molecular Mechanisms of Hyperalphalipoproteinemia
2. CETP Deficiency and Concerns in CETP Inhibitor Development
3. Degenerated HDL and Its Clinical Implications
4. HDL Apoprotein Mimetic Peptides as Antiinflammatory Molecules
5. Reverse Cholesterol Transport in HDL Metabolism: Relevance to Atherosclerosis Progression and Cardiovascular Diseases
6. Role of ATP-Binding Cassette Transporters A1 and G1 in Reverse Cholesterol Transport and Atherosclerosis
7. Sphingosine-1-Phosphate and HDL Metabolism
8. Role of SR-BI in HDL Metabolism
9. Paraoxonase 1 and Its Clinical Relevance
10. MicroRNA Regulation of HDL Homeostasis
11. The Application of Proteomic Techniques in the Study of HDL Particle Characterization and Biomarker Discovery
12. Therapies Targeting HDLc Levels and HDL Function
